Back to Network
4
Shared Docs
4
Same-Page
4 / 4
Mentions
Document Mentions (4 shared documents)
2 mentions1 same-page
Page ?Same page
g/dL mg/dL mg/dL mg/dL U/L U/L U/L mg/dL g/dL g/dL g/dL mg/dL mg/dL HEMATOLOGY WBC NRBC% RBC Hemoglobin Hematocrit MCV MCH MCHC RDW-CV Platelet L 7.6 0.0 5.42 15.6 47.8 88.2 28.8 32.6 12.8 338 4.3-11.1 4.46-5.78 13.6-17.6 40.2-51.4 82.5-96.5 27.1-34.9 33.0-37.0 12
rovider: MD Chief Complaint: ENDO/LIPID Subjective: 66 YR OLD WHITE MALE WITH HX OF HYPERTRIGLYCERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRI L WAS 800 , NOW 431. STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERID MEDS DUE TO THEIR GI SIDE EFFECTS. HX OF OBSTRUCTUVE SLEEP APNEA X 5 YEARS
2 mentions1 same-page
Page ?Same page
g/dL mg/dL mg/dL mg/dL U/L U/L U/L mg/dL g/dL g/dL g/dL mg/dL mg/dL HEMATOLOGY WBC NRBC% RBC Hemoglobin Hematocrit MCV MCH MCHC RDW-CV Platelet L 7.6 0.0 5.42 15.6 47.8 88.2 28.8 32.6 12.8 338 4.3-11.1 4.46-5.78 13.6-17.6 40.2-51.4 82.5-96.5 27.1-34.9 33.0-37.0 12
rovider: MD Chief Complaint: ENDO/LIPID Subjective: 66 YR OLD WHITE MALE WITH HX OF HYPERTRIGLYCERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRI L WAS 800 , NOW 431. STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERID MEDS DUE TO THEIR GI SIDE EFFECTS. HX OF OBSTRUCTUVE SLEEP APNEA X 5 YEARS
2 mentions1 same-page
Page ?Same page
g/dL mg/dL mg/dL mg/dL U/L U/L U/L mg/dL g/dL g/dL g/dL mg/dL mg/dL HEMATOLOGY WBC NRBC% RBC Hemoglobin Hematocrit MCV MCH MCHC RDW-CV Platelet L 7.6 0.0 5.42 15.6 47.8 88.2 28.8 32.6 12.8 338 4.3-11.1 4.46-5.78 13.6-17.6 40.2-51.4 82.5-96.5 27.1-34.9 33.0-37.0 12
1 Provider: Chief Complaint: ENDO/LIPID Subjective: 66 YR OLD WHITE MALE WITH HX OF HYPERTRIGLYCERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRI L WAS 800 , NOW 431. STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERID MEDS DUE TO THEIR GI SIDE EFFECTS. HX OF OBSTRUCTUVE SLEEP APNEA X 5 YEARS
Sponsored
2 mentions1 same-page
Page ?Same page
g/dL mg/dL mg/dL mg/dL U/L U/L U/L mg/dL g/dL g/dL g/dL mg/dL mg/dL HEMATOLOGY WBC NRBC% RBC Hemoglobin Hematocrit MCV MCH MCHC RDW-CV Platelet L 7.6 0.0 5.42 15.6 47.8 88.2 28.8 32.6 12.8 338 4.3-11.1 4.46-5.78 13.6-17.6 40.2-51.4 82.5-96.5 27.1-34.9 33.0-37.0 12
1 Provider: Chief Complaint: ENDO/LIPID Subjective: 66 YR OLD WHITE MALE WITH HX OF HYPERTRIGLYCERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRI L WAS 800 , NOW 431. STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERID MEDS DUE TO THEIR GI SIDE EFFECTS. HX OF OBSTRUCTUVE SLEEP APNEA X 5 YEARS
Sponsored
Mutual Connections (91)
Entities connected to both RDW-CV and TRI L
Jeffrey Epstein
PERSON18 w/ RDW-CV·4 w/ TRI
George W. Bush
PERSON17 w/ RDW-CV·4 w/ TRI
Ghislaine Maxwell
PERSON16 w/ RDW-CV·4 w/ TRI
Vascepa
ORGANIZATION15 w/ RDW-CV·4 w/ TRI
Springfield
LOCATION14 w/ RDW-CV·3 w/ TRI
Metropolitan Correctional Center
ORGANIZATION13 w/ RDW-CV·4 w/ TRI
LL
Low LI
PERSON12 w/ RDW-CV·4 w/ TRI
PHILIPS RESPIRONICS
ORGANIZATION11 w/ RDW-CV·4 w/ TRI
Special Housing Unit
ORGANIZATION12 w/ RDW-CV·3 w/ TRI
Discontinued Laboratory
ORGANIZATION11 w/ RDW-CV·4 w/ TRI
Smallpox Series Administration: History
ORGANIZATION11 w/ RDW-CV·4 w/ TRI
Varicella Series Administration: History Unknown
ORGANIZATION11 w/ RDW-CV·4 w/ TRI
New Radiology
ORGANIZATION10 w/ RDW-CV·4 w/ TRI
Achilles
PERSON10 w/ RDW-CV·3 w/ TRI
VB
Vesicular Breath Sounds Bilaterally
PERSON9 w/ RDW-CV·4 w/ TRI
Orthopedic/Rheumatology
ORGANIZATION10 w/ RDW-CV·2 w/ TRI
NEW YORK MCC
ORGANIZATION9 w/ RDW-CV·3 w/ TRI
HYPERT
ORGANIZATION8 w/ RDW-CV·4 w/ TRI
JO
Joaquin
PERSON9 w/ RDW-CV·2 w/ TRI
Sickle Cell Trait/Disease
ORGANIZATION7 w/ RDW-CV·4 w/ TRI